do glp 1 medications cause anxiety The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy Exploring The Gut-Brain Connection |

While these medications create a powerful sensation of reduced stomach capacity, the reality involves functional rather than structural changes

If one medication leads to more significant weight loss and improved metabolic health, the long-term benefits may outweigh the short-term cost difference

Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis combining 177 randomized controlled trials with a median follow-up of 26 weeks

This should be balanced against potential negative effects on body composition, bone density and frailty fractures [90, 91]

In these circumstances, the use of the SGLT2 inhibitor may be suspended for the period in which the diet is being followed

The drug testing process includes safeguards specifically designed to protect people taking legitimate medications